Study results from University of Alabama update understanding of HIV/AIDS co-infection
2009 JUL 13 - (NewsRx.com) -- "The current study evaluates one of four pilot sites initiated in Cambodia to establish feasible and effective ways to manage patients with human immunodeficiency virus (HIV) infection and tuberculosis (TB). To measure the costs of intensified case finding (ICF) and isoniazid preventive therapy (IPT) services for HIV-infected patients in Battambang Province, Cambodia," scientists in the United States report. "We analyzed cost data retrospectively from September 2003 to February 2006 using a microcosting or ingredients-based approach and interviewed clinic personnel to determine the cost of ICF and IPT per person. Adherence to IPT at Battambang IPT clinic was high (86%) relative to other reported studies of IPT among HIV patients in developing countries. The estimated cost per TB case averted through ICF was US$363, while the estimated cost per TB case averted through IPT was US$955. Economic evaluations of TB-HIV integrated services are necessary as countries move to establish or scale-up these services," wrote B.S. Sutton and colleagues, University of Alabama. The researchers concluded: "Based upon the estimated effectiveness of ICF and IPT used by other studies examining the provision of integrated HIV-TB services, the cost per TB case prevented by ICF and IPT in Battambang, Cambodia, is less than the reported cost of treating a new smear-positive TB case.." Sutton and colleagues published their study in International Journal of Tuberculosis and Lung Disease (The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia. International Journal of Tuberculosis and Lung Disease, 2009;13(6):713-718). For additional information, contact B.S. Sutton, University of Alabama, Dept. of Finance Economics & Quantitat Methods, Business Engineering Complex 308C, 1530 3rd Avenue S, Birmingham, AL 35294, USA. The publisher's contact information for the International Journal of Tuberculosis and Lung Disease is: International Union Against Tuberculosis Lung Disease (I U a T L D), 68 Boulevard Saint-Michel, 75006 Paris, France. Keywords: United States, Birmingham, HIV/AIDS Co-Infection, AIDS, Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, Cutaneous Tuberculosis, Drugs, HIV, Human Immunodeficiency Virus Bacterial Infection, Immunology, Infectious Disease, Isoniazid, Lung Disease, Mycobacteria, Mycobacterium Tuberculosis, Pharmaceuticals, Pulmonology, Respiratory Infection, Sexually Transmitted Disease, Therapy, Treatment, Viral, Virology, University of Alabama. This article was prepared by Tuberculosis Week editors from staff and other reports. Copyright 2009, Tuberculosis Week via NewsRx.com.
|
